News

Me’s sale to Regeneron is not yet a done deal. The privacy ombudsman is scheduled to report on the privacy aspects of the ...
Me has a path to a higher purchase price than the $256 million offered by biotech giant Regeneron after the genetic-testing ...
The judge overseeing the bankruptcy of 23andMe questioned the limits proposed for a second auction that is designed to push ...
Regeneron Pharmaceuticals said on Monday it will buy genomics firm 23andMe Holding for $256 million through a bankruptcy ...
Recently, Regeneron ( REGN -1.41%) entered an agreement to acquire 23andMe for $256 million, which is a tiny fraction of its ...
In trying to lead before the system could follow, 23andMe outpaced the very guardrails that might have legitimized it”: A ...
We’ve entered an era where biometric identity is currency. Regeneron just cornered a market without asking the public, the ...
When direct-to-consumer genetic testing company 23andMe Holding Co. and its affiliates (together, “23andMe”) filed for chapter 11 bankruptcy on ...